Stay updated on Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedEnrollment is now closed with a note that participants are no longer being sought. The page's navigation and headings were updated (e.g., addition of 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and the formatting change from 'Intervention / Treatment' to 'Intervention/Treatment'), along with a page revision tag 'Revision: v3.6.0'.SummaryDifference0.4%

- Check20 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a small update to the page metadata or layout without altering study content.SummaryDifference0.0%

- Check41 days agoChange DetectedThe revision label updated from v3.5.3 to v3.5.4, indicating a new version of the page template or content deployment. This reflects a deployment of an updated page version rather than a change to visible content.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page’s displayed software/webpage revision version was updated from v3.5.2 to v3.5.3 without changing any underlying study details.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check99 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.